½ÃÀ庸°í¼­
»óǰÄÚµå
1675824

¼¼°èÀÇ È£Èí±â °ü¸® ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø : Á¦Ç°º°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)

Respiratory Care Devices Market Size, Share, Trends and Forecast by Product, Indication, End User, and Region, 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 147 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

È£Èí±â °ü¸® ±â±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 235¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. IMARC GroupÀº 2033³â¿¡´Â 435¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 7.1%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÇöÀç ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ±â¼ú ¹ßÀü, È£Èí±â °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ºÏ¹Ì ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

È£Èí °ü¸® ÀåÄ¡´Â Æó Áúȯ ȯÀÚÀÇ Áø´Ü, Ä¡·á, Æò°¡ ¹× Ä¡·á¿¡ »ç¿ëµÇ´Â ÀÇ·á±â±â¸¦ ¸»ÇÕ´Ï´Ù. ºÐ¹«±â, ÈíÀÔ±â, ±âµµ ¾ç¾Ð(PAP) ÀåÄ¡, ÆóȰ·®°è, °¡½À±â µîÀº °¡Àå ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â È£Èí °ü¸® ÀåÄ¡ Áß ÀϺÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â ÁÖ·Î Áø´Ü, Ä¡·á ¹× ¸ð´ÏÅ͸µ ±â´ÉÀ» ¼öÇàÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â Æó¿¡ ÃæºÐÇÑ ¾çÀÇ »ê¼Ò¸¦ °ø±ÞÇÏ°í ±× °úÁ¤¿¡¼­ ¸·ÈûÀ» ¹æÁöÇÏ¿© ¿øÈ°ÇÑ È£Èí °úÁ¤À» º¸ÀåÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä, °áÇÙ°ú °°Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù. ÁÂ½Ä »ýȰ°ú ½ºÆ®·¹½º°¡ ¸¹Àº ÀÏ»ó »ýȰÀº Èí¿¬ÀÚ Áõ°¡ ¹× À½ÁÖÀ² Áõ°¡¿Í ÇÔ²² Æó¾Ï ¹× ±âŸ ½É°¢ÇÑ È£Èí±â ÁúȯÀÇ ¹ß»ý·ü Áõ°¡¸¦ ÃÊ·¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì¼÷¾Æ Ãâ»ê Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡µµ È£Èí±â ÄÉ¾î ±â±â¿¡ ´ëÇÑ ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¹Ì¼÷¾Æ ½Å»ý¾Æ³ª ³ëÀÎ ¸ðµÎ ¸é¿ªÃ¼°è°¡ ¾àÇÑ °æÇâÀÌ ÀÖ¾î ÀΰøÈ£ÈíÀ» ¿ëÀÌÇÏ°Ô ÇÏ°í ½Å»ý¾Æ È£Èí°ï¶õÁõÈıº(RDS)°ú °°Àº È£ÈíÀå¾Ö¸¦ ¿¹¹æÇϱâ À§ÇØ ´Ù¾çÇÑ È£Èíº¸Á¶±â±¸°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÇ·áºñ Áõ°¡¿Í ¼ÒÇü ±â±â ½ÃÀå °³Ã´ µî ´Ù¸¥ ¿äÀε鵵 ½ÃÀåÀ» ´õ¿í °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾çÁúÀÇ ÀÇ·á½Ã¼³À» ´©±¸³ª ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çϱâ À§ÇÑ Á¤ºÎ¿Í ºñÁ¤ºÎ±â±¸(NGO) ¸ðµÎÀÇ ³ë·Âµµ »õ·Î¿î ÀÇ·á ÀÎÇÁ¶óÀÇ °³Ã´ ¹× ±âÁ¸ ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±°ú ÇÔ²² ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ Àü¸ÁÀ» °¡Á®´ÙÁÖ°í ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • È£Èí °ü¸® ÀåÄ¡¶õ ¹«¾ùÀΰ¡?
  • È£Èí±â ÄÉ¾î ±â±â ½ÃÀå ±Ô¸ð´Â?
  • 2025-2033³â ¼¼°è È£Èí±â ÄÉ¾î ±â±â ½ÃÀå ¼ºÀå·ü Àü¸ÁÀº?
  • ¼¼°è È£Èí±â ÄÉ¾î ±â±â ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº?
  • Á¦Ç°À» ±â¹ÝÀ¸·Î ÇÑ È£Èí °ü¸® ÀåÄ¡ ½ÃÀåÀÇ ¼¼°è ÁÖ¿ä ºÎ¹®Àº ¹«¾ùÀΰ¡?
  • Àü ¼¼°è È£Èí±â °ü¸® ±â±â ½ÃÀåÀÇ ÀûÀÀÁõº° ÁÖ¿ä ºÎ¹®Àº ¹«¾ùÀΰ¡?
  • ÃÖÁ¾ »ç¿ëÀÚº°·Î È£Èí °ü¸® ÀåÄ¡ ½ÃÀåÀÇ ¼¼°è ÁÖ¿ä ºÎ¹®Àº?
  • Àü ¼¼°è È£Èí °ü¸® ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°è È£Èí±â ÄÉ¾î ±â±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ Á¢±Ù
    • Åé´Ù¿î Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ È£Èí±â °ü¸® ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ºÐ¼® : Á¦Ç°º°
  • ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°
  • ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
  • ½ÃÀå ºÐ¼® : Áö¿ªº°
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Ä¡·á ±â±â
    • ÁÖ¿ä ±â±â
      • ±âµµ¾ç¾Ð(PAP) ±â±â
      • ÀΰøÈ£Èí±â
      • ³×ºæ¶óÀÌÀú
      • °¡½À±â
      • ÈíÀÔ±â
      • ±âŸ
  • ¸ð´ÏÅ͸µ ±â±â
    • ÁÖ¿ä ±â±â
      • »êÈ£ Æ÷È­µµ ÃøÁ¤±â
      • °¡½º ºÐ¼® Àåºñ
      • ±âŸ
  • Áø´Ü ±â±â
    • ÁÖ¿ä ±â±â
      • ÆóȰ·®°è
      • ¼ö¸é´Ù¿øºÐ¼® ±â±â
      • ÇÇÅ© À¯·®°è
      • ±âŸ
  • ¼Ò¸ðǰ ¹× ºÎ¼Óǰ
    • ÁÖ¿ä À¯Çü
      • ¸¶½ºÅ©
      • ÀÏȸ¿ë ¼Ò»ý±â
      • È£Èí ȸ·Î
      • ±â°ü Àý°³ Æ©ºê
      • ºñ°­ ij´¼¶ó
      • ±âŸ

Á¦7Àå ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°

  • ¸¸¼º Æó¼â¼º ÆóÁúȯ(COPD)
  • õ½Ä
  • ¼ö¸é¹«È£Èí
  • °¨¿°Áõ
  • ±âŸ

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ÀçÅÃÄ¡·á
  • ¿Ü·¡ Áø·á ¼¾ÅÍ
  • ±âŸ

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå PorterÀÇ Five Forces ºÐ¼®

  • °³¿ä
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Philips Healthcare
    • ResMed
    • Chart Industries Inc.
    • Hamilton Medical
    • Medtronic
    • Masimo
    • Dragerwerk
    • Invacare Corporation
    • Allied Healthcare Products Inc
    • 3B Medical Inc
    • Air Liquide
    • Fisher & Paykel Healthcare
    • GE Healthcare
    • VYAIRE MEDICAL INC
    • Rotech Healthcare Inc
LSH 25.04.16

The global respiratory care devices market size was valued at USD 23.5 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 43.5 Billion by 2033, exhibiting a CAGR of 7.1% during 2025-2033. North America currently dominates the market. The increasing prevalence of respiratory diseases, rising geriatric population, technological advancements, and growing awareness about respiratory health, are factors driving the market across the North American region.

Respiratory care devices refer to the medical equipment used for the diagnosis, treatment, assessment and care of patients suffering from pulmonary diseases. Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices. These devices primarily perform diagnostic, therapeutic and monitoring functions. They aid in ensuring a smooth respiration process by providing an adequate amount of oxygen to the lungs and preventing any blockage in the process.

The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and tuberculosis, represent as the key factors driving the growth of the market. Sedentary lifestyles and stressful routines, in confluence with the growing number of smokers and rate of alcohol consumption, have resulted in rising incidences of lung cancer and other severe respiratory conditions. Also, the increasing number of premature births, along with the growing geriatric population are also impacting the demand for respiratory care devices. Both premature newborns and elderly tend to have weak immune systems and require various breathing support devices for facilitating artificial breathing and preventing respiratory disorders, including newborn respiratory distress syndrome (RDS). Other factors, such as the increasing healthcare expenditure and the development of miniature devices are projected to drive the market further. Significant efforts by both the government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all, along with developing new and improving the existing healthcare infrastructure are also creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Product:

  • Therapeutic Devices
  • Positive Airway Pressure (PAP) Devices
  • Ventilators
  • Nebulizers
  • Humidifiers
  • Inhalers
  • Other
  • Monitoring Devices
  • Pulse Oximeters
  • Gas Analyzers
  • Others
  • Diagnostic Devices
  • Spirometers
  • Polysomnography Devices
  • Peak Flow Meters
  • Others
  • Consumables and Accessories
  • Masks
  • Disposable Resuscitators
  • Breathing Circuits
  • Tracheostomy Tubes
  • Nasal Cannulas
  • Others

Breakup by Indication:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Sleep Apnea
  • Infectious Disease
  • Others

Breakup by End-User:

  • Hospitals
  • Home Care Settings
  • Ambulatory Care Centers
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, ResMed, Chart Industries Inc., Hamilton Medical, Medtronic, Masimo, Dragerwerk, Invacare Corporation, Allied Healthcare Products Inc, 3B Medical Inc., Air Liquide, Fisher & Paykel Healthcare, GE Healthcare, Vyaire Medical Inc., Rotech Healthcare Inc., etc.

Key Questions Answered in This Report

  • 1.What is respiratory care devices?
  • 2.How big is the respiratory care devices market?
  • 3.What is the expected growth rate of the global respiratory care devices market during 2025-2033?
  • 4.What are the key factors driving the global respiratory care devices market?
  • 5.What is the leading segment of the global respiratory care devices market based on the product?
  • 6.What is the leading segment of the global respiratory care devices market based on indication?
  • 7.What is the leading segment of the global respiratory care devices market based on end user?
  • 8.What are the key regions in the global respiratory care devices market?
  • 9.Who are the key players/companies in the global respiratory care devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Care Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by Indication
  • 5.6 Market Breakup by End-User
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Product

  • 6.1 Therapeutic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Major Devices
      • 6.1.2.1 Positive Airway Pressure (PAP) Devices
      • 6.1.2.2 Ventilators
      • 6.1.2.3 Nebulizers
      • 6.1.2.4 Humidifiers
      • 6.1.2.5 Inhalers
      • 6.1.2.6 Others
    • 6.1.3 Market Forecast
  • 6.2 Monitoring Devices
    • 6.2.1 Market Trends
    • 6.2.2 Major Devices
      • 6.2.2.1 Pulse Oximeters
      • 6.2.2.2 Gas Analyzers
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Diagnostic Devices
    • 6.3.1 Market Trends
    • 6.3.2 Major Devices
      • 6.3.2.1 Spirometers
      • 6.3.2.2 Polysomnography Devices
      • 6.3.2.3 Peak Flow Meters
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4 Consumables and Accessories
    • 6.4.1 Market Trends
    • 6.4.2 Major Types
      • 6.4.2.1 Masks
      • 6.4.2.2 Disposable Resuscitators
      • 6.4.2.3 Breathing Circuits
      • 6.4.2.4 Tracheostomy Tubes
      • 6.4.2.5 Nasal Cannulas
      • 6.4.2.6 Others
    • 6.4.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sleep Apnea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Infectious Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Care Settings
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Care Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porter's Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Philips Healthcare
    • 13.3.2 ResMed
    • 13.3.3 Chart Industries Inc.
    • 13.3.4 Hamilton Medical
    • 13.3.5 Medtronic
    • 13.3.6 Masimo
    • 13.3.7 Dragerwerk
    • 13.3.8 Invacare Corporation
    • 13.3.9 Allied Healthcare Products Inc
    • 13.3.10 3B Medical Inc
    • 13.3.11 Air Liquide
    • 13.3.12 Fisher & Paykel Healthcare
    • 13.3.13 GE Healthcare
    • 13.3.14 VYAIRE MEDICAL INC
    • 13.3.15 Rotech Healthcare Inc
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦